Evaluating the Safety and Performance of the KidneYou App for Chronic Kidney Disease: Protocol for an Italian Multicenter, Randomized, Open-Label, Premarket Study
The results of this trial will guide further studies on the impact of digital devices to help patients with CKD in improving their condition more effectively and sustain a healthier lifestyle, which could ultimately lead to improved disease outcomes.
Authors
- Andreana Foresta (ORCID: https://orcid.org/0000-0002-6971-1674)
- Anna Rita Maurizi
- Marco Gnesi (ORCID: https://orcid.org/0000-0001-6022-6325)
- Cesira Cafiero (ORCID: https://orcid.org/0000-0002-0935-5698)
- Marco Gorini (ORCID: https://orcid.org/0009-0008-1455-3884)
- Paola Maria Acquaviva (ORCID: https://orcid.org/0000-0001-6620-3220)
- Francesca Mastromauro
- Marco Fiorentino (ORCID: https://orcid.org/0000-0001-7334-8372)
- Massimiliano Beccaria (ORCID: https://orcid.org/0000-0002-0901-4981)
- Giorgia Campilongo
- Loreto Gesualdo
Institutions
- AstraZeneca (Italy) (IT)
- Advicenne Pharma (France) (FR)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- JMIR Research Protocols
- Published
- 2025-11-05
- DOI
- https://doi.org/10.2196/75306
- Primary Topic
- Mobile Health and mHealth Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00